{"Ticker": "WST", "Company": "West Pharmaceutical Services", "Sector": "Health Care", "Updated": "2023-04-11", "Rating": [{"Date": "2023-04-11", "Rating": "Upgrade", "Organization": "Stephens", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$330 to $400"}, {"Date": "2022-12-14", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$250"}, {"Date": "2022-11-30", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$250"}, {"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$385 to $250"}, {"Date": "2020-11-10", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$350"}, {"Date": "2020-10-14", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Equal-Weight", "Target_Change": "$300"}, {"Date": "2020-07-21", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$280"}, {"Date": "2020-04-24", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Underperform to Neutral", "Target_Change": "$145 to $200"}, {"Date": "2019-12-12", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Neutral to Underperform", "Target_Change": ""}, {"Date": "2019-07-26", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Underperform to Neutral", "Target_Change": ""}, {"Date": "2019-05-01", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$122"}, {"Date": "2019-04-23", "Rating": "Initiated", "Organization": "William Blair", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2018-04-25", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Neutral to Underperform", "Target_Change": ""}, {"Date": "2018-01-24", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2017-10-17", "Rating": "Downgrade", "Organization": "BofA/Merrill", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2017-10-03", "Rating": "Initiated", "Organization": "Stephens", "Rating_Change": "Equal-Weight", "Target_Change": ""}, {"Date": "2017-09-15", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2016-10-28", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Market Perform to Outperform", "Target_Change": ""}, {"Date": "2016-09-21", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Outperform to Market Perform", "Target_Change": ""}, {"Date": "2016-03-22", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2010-05-14", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$41 to $44"}, {"Date": "2010-02-23", "Rating": "Initiated", "Organization": "Jefferies & Co", "Rating_Change": "Buy", "Target_Change": "$45"}, {"Date": "2008-12-19", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$41"}, {"Date": "2008-12-19", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": ""}]}